CONTAINMENT TECHNOLOGY

The most dangerous risks in your facility are often invisible; a stray airborne particle from a potent ingredient can compromise a product or, more critically, threaten the health of your operators. The challenge is creating an environment where high-potency processing and operator safety coexist without friction.

We eliminate this uncertainty by embedding total barrier protection into the core of your facility's operational flow. By shifting the focus from individual machines to a comprehensive containment strategy, we create an environment where high-potency processing and operator safety coexist without friction.

We transform technical specifications into operational certainty by deploying specialized Isolators and Restricted Access Barrier Systems (RABS) that neutralize risk at the source. Our engineering teams configure precise pressure cascades and air-lock transitions, turning airflow into a constant, protective shield that remains vigilant even during the most volatile stages of production. This rigorous approach to containment provides the necessary stability for diverse sectors, whether you are managing sensitive oncology and hormone lines or meeting the precision-heavy demands of Data Centers and Battery Giga-factories. By establishing this uncompromising backbone of safety, we empower your team to focus on innovation, knowing their environment and their results are fully protected.

We transform technical specifications into operational certainty by deploying specialized Isolators and Restricted Access Barrier Systems (RABS) that neutralize risk at the source. Our engineering teams configure precise pressure cascades and air-lock transitions, turning airflow into a constant, protective shield that remains vigilant even during the most volatile stages of production. This rigorous approach to containment provides the necessary stability for diverse sectors, whether you are managing sensitive oncology and hormone lines or meeting the precision-heavy demands of Data Centers and Battery Giga-factories. By establishing this uncompromising backbone of safety, we empower your team to focus on innovation, knowing their environment and their results are fully protected.

The Unified Containment Ecosystem

Slide 1
Slide 2
Slide 3
Slide 4

Primary Barrier Integration

Solid & Liquid Isolators: Solid & Liquid Isolators:High-performance enclosures designed for the precision weighing, sampling, and dispensing of potent APIs and chemicals.

RABS (Restricted Access Barrier Systems): Advanced barriers that provide a controlled aseptic environment for filling lines while allowing for safe manual intervention.

Multi-Utility Containment Units: Flexible, modular isolators engineered to handle diverse product lines without the risk of cross-contamination. Compact Substations (CSS):Turnkey units integrating breakers, transformers, and LT distribution.

Data 1
Data 2
Data 3

Atmospheric & Pressure Management

Pressure Cascade Systems: Custom-engineered air management that maintains specific pressure differentials to trap hazardous particulates.

VHP & Misting Decontamination: Integrated sterilization units that provide deep-cleaning and neutralization between production batches.

Negative Pressure Hubs: Specialized zones designed for the safe handling of volatile or extremely potent biological and chemical agents.

Protection 1
Protection 2
Protection 3

Containment Engineering & Optimization

Critical Gap Analysis: Detailed technical audits to assess and convert standard facilities into high-potency production lines (Onco/Hormone).

Retrofit Engineering: The seamless integration of modern containment barriers into your existing machinery to meet updated OEL standards.

Validation & OEL Mapping: Comprehensive testing and mapping to ensure your containment systems meet international regulatory and safety benchmarks.

OEL Specific Systems

The most effective safety strategy begins exactly where the hazard is most concentrated, neutralizing airborne particles at the source through specialized Isolators and Restricted Access Barrier Systems (RABS). By aligning our technology with specific Operator Exposure Levels (OEL), we engineer sealed environments that preserve product purity while ensuring not a single microscopic particle reaches your team.

We transform your facility's air into an active protective shield by configuring precise pressure cascades, where negative pressure ensures that even during a seal compromise, airflow remains directed toward the hazard and away from personnel. This technical mastery of "transfer logic", integrating sophisticated airlocks and decontamination systems, ensures that materials and people move seamlessly without breaking the hazardous seal, providing a unified backbone of safety for high-stakes sectors like Oncology, Data Centers, and Battery Manufacturing.

Electrical Panels

Existing Facility Upgrade

If you already have a containment facility, we can help with optimising your containment processes according to the respective OEL levels for:

  • Existing Process Machinery in Isolators - Restricted Access Barrier systems
  • Personnel protection measures
  • Airlock and pressure cascades
  • Material Flow methodology
  • Decontamination measures

Critical Gap Analysis

If you have general facility and equipments and want to convert in potent (onco, hormone, other potent) products then we will help you with gap analysis and customized containment system with your existing equipment.

We consider the opinions for and against open and closed containment systems, and analyse the potential of multi utility Isolators versus dedicated Equipment for Specific operations.

Related Services

Engineering Consultancy

Investors in our businesses face growing competition and regulatory pressure.

Read More
Containment Consultancy

The handling of extremely potent active ingredients is on the rise in contemporary pharmaceutical production facilities.

Read More
Technology Transfer

The most straightforward reason for any company to participate in a technology transfer...

Read More
Project Feasibility

HVAX strongly recommends that a feasibility study is conducted prior to a pharmaceutical project’s undertaking.

Read More